Home > News > Nano Killers Aim at Mini Tumors
June 22nd, 2004
Nano Killers Aim at Mini Tumors
A company called Kereos is developing a pair of nanotechnologies to identify tumors that measure just 1 mm in diameter, then kill them with a tiny but precise amount of a chemotherapy drug. The technologies, if approved by the Food and Drug Administration, would not only find cancers in their earliest stages before they can do damage or spread, but also deliver a small amount of a drug targeted directly at tumors, which would cause little or no side effects.
Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014
NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014
SentiMag® Now Available in Australia and New Zealand July 21st, 2014
More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014